Man Group’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$671K Buy
+26,911
New +$700K ﹤0.01% 1995
2023
Q3
– Sell
-83,473
Closed -$277K – 2149
2023
Q2
$277K Buy
+83,473
New +$300K ﹤0.01% 1743

Other funds holding TNGX

Man Group's TNGX Position: Q3 2026 in Review

Man Group opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 26,911 shares worth $671K. The stake represents ﹤0.01% of the portfolio and ranks #1995 among its holdings. This is a return to the name: Man Group previously reported a position in TNGX as recently as Q2 2023.

Man Group first reported a position in TNGX in Q2 2023 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Man Group held 26,911 shares of Tango Therapeutics worth $671K as of Q3 2026.
  • Tango Therapeutics was a new Man Group position in Q3 2026.
  • Tango Therapeutics made up ﹤0.01% of Man Group's portfolio in Q3 2026, its #1995 holding.
  • Man Group first reported a position in Tango Therapeutics in Q2 2023 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.